RFK Jr.'s FDA staff cuts claimed key user fee negotiators, threatening renewal talks with pharma: Reuters
Staff cuts at the FDA have reached key negotiators in charge of hashing out terms with the industry to renew the agency's user fee collection program, which helps fund the FDA and keeps its drug review process on track, Reuters reports.
Staff cuts at the FDA have reached key negotiators in charge of hashing out terms with the industry to renew the agency's user fee collection program, which helps fund the FDA and keeps its drug review process on track, Reuters reports.
